Aurinia Pharmaceuticals Inc (AUPH)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

#1203-4464 MARKHAM STREET VICTORIA BC, BRITISH COLUMBIA, CANADA V8Z 7X8

Aurinia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of immunosuppressive therapeutics.

Data as of 2021-05-08 11:24:59 -0400
Market Cap1.3 Billion Shares Outstanding128.121 Million Avg 30-day Volume3.854 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.65234 52-week High/Low20.5 / 10.03 Next Earnings Date2021-08-10 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from AUPH instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
Only subscribers may access this information
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AUPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AUPH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

1 Thousand total shares from 1 transactions

Open Market Sells (S)

40 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

80 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HUIZINGA ROBERT BINDERT EX VICE PRESIDENT OF RESEARCH

  • Officer
143,592 2021-05-11 2

MILLER JOSEPH M CHIEF FINANCIAL OFFICER

  • Officer
1,000 2021-05-11 2

SOLOMONS NEIL CHIEF MEDICAL OFFICER

  • Officer
187,299 2021-03-12 2

MILNE GEORGE M JR

  • Director
45,000 2021-03-05 2

HAYDEN MICHAEL R

  • Director
95,000 2021-01-29 2

LEVERSAGE JILL

  • Director
2,600 2021-01-29 2

ROBERTSON STEPHEN P. EVP, GENERAL COUNSEL

  • Officer
2,720 2021-01-28 2

BILLEN DANIEL

  • Director
20,000 2021-01-01 1

COLAO MASSIMILANO CHIEF COMMERCIAL OFFICER

  • Officer
8,200 2021-01-01 1

DONLEY MATTHEW MAXWELL EX VP, INTERN'L OPERATIONS

  • Officer
0 2021-01-01 1

GREENLEAF PETER CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
8,328 2021-01-01 1

HAGAN JOSEPH P

  • Director
3,500 2021-01-01 1

JAYNE DAVID R.W.

  • Director
30,000 2021-01-01 1

MACKAY-DUNN R. HECTOR

  • Director
1,500 2021-01-01 1

MARTIN MICHAEL ROBERT CHIEF BUSINESS OFFICER

  • Officer
201,861 2021-01-01 1

WALBERT TIMOTHY P

  • Director
0 2021-01-01 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HUIZINGA ROBERT BINDERT - Officer EX VICE PRESIDENT OF RESEARCH

2021-05-11 17:22:59 -0400 2021-05-11 M 40,000 d 0 direct

HUIZINGA ROBERT BINDERT - Officer EX VICE PRESIDENT OF RESEARCH

2021-05-11 17:22:59 -0400 2021-05-11 M 40,000 $3.02 a 143,592 direct

MILLER JOSEPH M - Officer CHIEF FINANCIAL OFFICER

2021-05-11 16:53:55 -0400 2021-05-11 P 1,000 $9.74 a 1,000 direct

SOLOMONS NEIL - Officer CHIEF MEDICAL OFFICER

2021-03-15 16:36:13 -0400 2021-03-12 M 40,000 $3.02 a 227,299 direct 1.3015 -7.0137 -10.7014 1.3015 2 -14.1721 25

SOLOMONS NEIL - Officer CHIEF MEDICAL OFFICER

2021-03-15 16:36:13 -0400 2021-03-12 M 40,000 d 0 direct

SOLOMONS NEIL - Officer CHIEF MEDICAL OFFICER

2021-03-15 16:36:13 -0400 2021-03-12 S 40,000 $13.49 d 187,299 direct 1.3015 -7.0137 -10.7014 1.3015 2 -14.1721 25

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 22:15:03 UTC -1.0702 1.1202 600000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 21:45:03 UTC -1.0683 1.1183 600000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 21:15:03 UTC -1.0683 1.1183 600000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 20:45:03 UTC -1.1125 1.1625 650000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 20:15:03 UTC -1.1125 1.1625 650000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 19:45:03 UTC -1.1125 1.1625 650000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 19:15:02 UTC -1.1125 1.1625 650000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 18:45:02 UTC -1.0545 1.1045 650000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 18:15:03 UTC -1.0545 1.1045 650000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 17:45:03 UTC -1.0545 1.1045 650000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 17:15:04 UTC -1.0545 1.1045 650000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 16:45:04 UTC -1.0154 1.0654 650000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 16:15:04 UTC -1.0154 1.0654 700000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 15:45:03 UTC -1.0154 1.0654 700000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 15:15:03 UTC -1.0154 1.0654 700000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 14:45:03 UTC -0.9865 1.0365 700000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 14:15:03 UTC -0.9865 1.0365 700000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 13:45:04 UTC -0.9865 1.0365 700000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 13:15:04 UTC -0.9865 1.0365 650000
AURINIA PHARMACEUTICALS INC AUPH 2021-05-11 12:45:03 UTC -0.9865 1.0365 650000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund AUPH -290.0 shares, $-4207.9 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund AUPH -73.0 shares, $-1059.23 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund AUPH -293.0 shares, $-4251.43 2020-03-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund AUPH -35700.0 shares, $-463564.5 2021-03-31 N-PORT

Elevate your investments